在Hashimoto甲状腺炎中眼动脱敏和再处理的心理和免疫益处:随机对照试验的初步发现
Maria-Magdalena Macarenco1, Cristian Opariuc-Dan1, Teodora Georgescu1
1Department of Psychology, University of Bucharest, Romania.
Psychoneuroendocrinology
|November 20, 2025
概括
眼动脱敏和再处理 (EMDR) 疗法显著改善了哈西莫托患者成年人的心理健康和生活质量.
科学领域:
- 心理神经免疫学 心理神经免疫学
- 自身免疫性疾病的研究.
- 创伤信息化的护理
背景情况:
- 哈西莫托甲状腺炎 (HT) 是一种慢性自身免疫性疾病,与心理困扰和早期创伤有关.
- 目前对HT的治疗主要集中在甲状腺激素替代上,对管理相关心理症状的选择有限.
研究的目的:
- 研究眼动脱敏和再处理 (EMDR) 作为哈西莫托甲状腺炎成年人的辅助疗法的疗效.
- 评估EMDR对HT患者心理功能和关键免疫标记 (抗TPO,抗TG) 的影响.
主要方法:
- 一项随机对照试验,涉及91名患有HT的成年人.
- 参与者被分配到EMDR加通常治疗 (TAU),安慰剂加TAU或单独TAU.
- 电子治疗治疗治疗方案针对疾病发病前的痛苦记忆;结果包括心理措施和甲状腺抗体.
主要成果:
- EMDR显著降低了抑郁症,焦虑,压力,分离,alexithymia和特征愤怒,同时改善了情绪调节和生活质量.
- 改善在3个月的随访后持续,通常优于安慰剂或TAU.
- 在EMDR组中发现了降低抗甲状腺过氧化酶 (抗TPO) 水平的趋势,尽管在纠正后的组之间没有统计学意义.
结论:
- 电子治疗疗法 (EMDR) 显示出作为哈西莫托甲状腺炎的辅助治疗的前景,有效地缓解心理痛苦.
- 初步发现表明EMDR可能会影响免疫标记物,这需要在更大的队列中进行进一步研究.
- 电子治疗疗法提供了一种潜在的途径,可以提高慢性自身免疫性疾病管理人员的整体幸福感.
相关概念视频
Desensitization and Tachyphylaxis
3.4K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
3.4K
Autoimmune Disorders
2.3K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
2.3K
Hyperthyroidism II: Pathophysiology
26
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
26
Graves' Disease I: Introduction
19
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
19
Graves Disease II: Pathophysiology
20
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor,...
20
Hypothyroidism II: Pathophysiology
20
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
20


